Login
|
New Account
AAAAAA
ITA
ENG
Results:
1-16
|
Table of contents of journal:
Results: 16
Thrombosis in acute coronary syndromes and coronary interventions
Authors:
Tolleson, TR Harrington, RA
Citation:
Tr. Tolleson et Ra. Harrington, Thrombosis in acute coronary syndromes and coronary interventions, CONTEMP CAR, 2, 1999, pp. 3-20
Mechanisms of platelet adhesion
Authors:
Plow, EF
Citation:
Ef. Plow, Mechanisms of platelet adhesion, CONTEMP CAR, 2, 1999, pp. 21-34
Glycoprotein IIb-IIIa in platelet aggregation and acute arterial thrombosis
Authors:
Law, DA Phillips, DR
Citation:
Da. Law et Dr. Phillips, Glycoprotein IIb-IIIa in platelet aggregation and acute arterial thrombosis, CONTEMP CAR, 2, 1999, pp. 35-66
Glycoprotein IIb/IIIa antagonists: Development of abciximab and pharmacology of select agents
Authors:
Coller, BS
Citation:
Bs. Coller, Glycoprotein IIb/IIIa antagonists: Development of abciximab and pharmacology of select agents, CONTEMP CAR, 2, 1999, pp. 67-89
Abciximab during percutaneous coronary intervention - The EPIC, EPILOG, and EPISTENT trials
Authors:
Lincoff, AM
Citation:
Am. Lincoff, Abciximab during percutaneous coronary intervention - The EPIC, EPILOG, and EPISTENT trials, CONTEMP CAR, 2, 1999, pp. 93-113
Eptifibatide in coronary intervention - The IMPACT trials
Authors:
O'Shea, C Tcheng, JE
Citation:
C. O'Shea et Je. Tcheng, Eptifibatide in coronary intervention - The IMPACT trials, CONTEMP CAR, 2, 1999, pp. 115-126
Tirofiban in coronary intervention - The RESTORE trial
Authors:
Salame, MY King, SB Chronos, NA
Citation:
My. Salame et al., Tirofiban in coronary intervention - The RESTORE trial, CONTEMP CAR, 2, 1999, pp. 127-142
The use of abciximab in therapy resistant unstable angina - Clinical and angiographic results of the CAPTURE pilot and the CAPTURE study
Authors:
van den Brand, MJBM Simoons, ML
Citation:
Mjbm. Van Den Brand et Ml. Simoons, The use of abciximab in therapy resistant unstable angina - Clinical and angiographic results of the CAPTURE pilot and the CAPTURE study, CONTEMP CAR, 2, 1999, pp. 143-168
Overview of the glycoprotein IIb/IIIa inhibitor interventional trials
Authors:
Lincoff, AM Topol, EJ
Citation:
Am. Lincoff et Ej. Topol, Overview of the glycoprotein IIb/IIIa inhibitor interventional trials, CONTEMP CAR, 2, 1999, pp. 169-197
Unstable angina: PARAGON, PURSUIT, PRISM, and PRISM-PLUS
Authors:
Moliterno, DJ White, HD
Citation:
Dj. Moliterno et Hd. White, Unstable angina: PARAGON, PURSUIT, PRISM, and PRISM-PLUS, CONTEMP CAR, 2, 1999, pp. 201-227
The use of glycoprotein IIb/IIIa inhibition in acute myocardial infarction
Authors:
Greenbaum, AB Harrington, RA Ohman, EM
Citation:
Ab. Greenbaum et al., The use of glycoprotein IIb/IIIa inhibition in acute myocardial infarction, CONTEMP CAR, 2, 1999, pp. 229-249
Economics of glycoprotein IIb/IIIa inhibition
Authors:
Mark, DB
Citation:
Db. Mark, Economics of glycoprotein IIb/IIIa inhibition, CONTEMP CAR, 2, 1999, pp. 253-266
Monitoring platelet aggregation
Authors:
Kleiman, NS Mazur, W Graziadei, N
Citation:
Ns. Kleiman et al., Monitoring platelet aggregation, CONTEMP CAR, 2, 1999, pp. 267-285
Oral platelet glycoprotein IIb/IIIa blockade
Authors:
Kereiakes, DJ Cannon, CP
Citation:
Dj. Kereiakes et Cp. Cannon, Oral platelet glycoprotein IIb/IIIa blockade, CONTEMP CAR, 2, 1999, pp. 287-314
Cerebrovascular aspects of glycoprotein IIb/IIIa inhibitors
Authors:
Sila, CA
Citation:
Ca. Sila, Cerebrovascular aspects of glycoprotein IIb/IIIa inhibitors, CONTEMP CAR, 2, 1999, pp. 315-326
The future of glycoprotein IIb/IIIa inhibitors
Authors:
Califf, RM Kong, DF
Citation:
Rm. Califf et Df. Kong, The future of glycoprotein IIb/IIIa inhibitors, CONTEMP CAR, 2, 1999, pp. 327-360
Risultati:
1-16
|